Deignan Charles A. 4
4 · Clearside Biomedical, Inc. · Filed Sep 23, 2021
Insider Transaction Report
Form 4
Deignan Charles A.
Chief Financial Officer
Transactions
- Sale
Common Stock
2021-09-21$6.41/sh−2,800$17,948→ 316,449 total
Footnotes (1)
- [F1]The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.